Rep. Maria Elvira Salazar Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Key Points

• Rep. Maria Elvira Salazar sold UnitedHealth Group shares worth between $1,001 and $15,000 on June 4, according to a filing disclosed July 7. The trade was made through her UBS brokerage account.
• UnitedHealth’s recent performance and outlook remain strong, with shares opening at $425.61 and the company reporting Q1 earnings of $7.23 per share, beating estimates. Revenue also topped expectations, and analysts currently rate the stock a Moderate Buy with a consensus target price of $414.75.
• The company is balancing positive catalysts and regulatory risks: it raised its quarterly dividend to $2.32 per share and is investing nearly $1.5 billion in AI for 2026, while an external audit supported most HouseCalls diagnoses and helped ease Medicare billing concerns. At the same time, litigation involving insurers and pharmacy laws keeps regulatory scrutiny in focus.

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on July 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 4th. The trade occurred in the Representative's "UBS BROKERAGE ACCOUNT" account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Voyager Technologies NYSE: VOYG on 6/15/2026.
• Purchased $15,001 - $50,000 in shares of Brookfield Renewable Partners NYSE: BEP on 6/4/2026.
• Purchased $1,001 - $15,000 in shares of Brookfield Renewable Partners NYSE: BEP on 6/4/2026.
• Purchased $1,001 - $15,000 in shares of Brookfield Renewable Partners NYSE: BEP on 6/3/2026.
• Purchased $1,001 - $15,000 in shares of Brookfield Renewable Partners NYSE: BEP on 6/2/2026.
• Purchased $15,001 - $50,000 in shares of Salesforce NYSE: CRM on 6/2/2026.
• Sold $15,001 - $50,000 in shares of Biogen NASDAQ: BIIB on 6/2/2026.
• Purchased $1,001 - $15,000 in shares of Brookfield Renewable Partners NYSE: BEP on 5/29/2026.
• Purchased $15,001 - $50,000 in shares of International Business Machines NYSE: IBM on 5/21/2026.
• Purchased $15,001 - $50,000 in shares of Datadog NASDAQ: DDOG on 5/19/2026.

UnitedHealth Group Price Performance

UNH opened at $425.61 on Thursday. The firm has a market capitalization of $386.52 billion, a PE ratio of 32.15, a price-to-earnings-growth ratio of 1.72 and a beta of 0.62. The business's 50-day moving average is $397.02 and its two-hundred day moving average is $337.55. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $430.77. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same period last year, the firm earned $7.20 earnings per share. UnitedHealth Group's revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, June 15th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group's dividend payout ratio is 70.09%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses in its HouseCalls home-visit unit were supported by patient medical records, which could help ease concerns about Medicare billing practices and reduce regulatory overhang. Reuters article
• Positive Sentiment: UnitedHealth is investing nearly $1.5 billion in AI for 2026 to expand automation and digital tools, which investors may view as a way to support efficiency and longer-term growth beyond cost savings. Yahoo Finance article
• Positive Sentiment: The company’s push to prioritize profitability over rapid growth, along with Optum expansion and improving margins, is being framed as a potential long-term turnaround catalyst. Yahoo Finance article
• Positive Sentiment: UnitedHealth also expanded coverage of Guardant Health’s Shield blood test for colorectal cancer screening, reinforcing its role in supporting emerging preventive-care tools. Yahoo Finance article
• Neutral Sentiment: Commentary highlighting healthcare-sector strength and a 12.41% rise in a major healthcare ETF may support sentiment for UNH, but it does not specifically change the company’s fundamentals. ETF Trends article
• Neutral Sentiment: Recent articles noting that UNH rebounded sharply in the first half and may still be undervalued suggest investors remain focused on the turnaround, though the pieces are largely opinion-based. Motley Fool article
• Negative Sentiment: New criticism from a Motley Fool piece argues that UnitedHealth may not be the best healthcare investment, which could weigh on sentiment even if it is not tied to a new company event. Motley Fool article
• Negative Sentiment: UnitedHealth and other insurers are suing states over laws targeting pharmacy businesses, and that legal fight may keep regulatory risk in focus for investors. New York Times article

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. HSBC upped their target price on UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a research report on Monday. Truist Financial upped their price objective on shares of UnitedHealth Group from $395.00 to $440.00 and gave the company a "buy" rating in a report on Monday, June 1st. Sanford C. Bernstein reiterated an "outperform" rating on shares of UnitedHealth Group in a research note on Tuesday, June 23rd. Morgan Stanley upped their price target on shares of UnitedHealth Group from $453.00 to $468.00 and gave the company an "overweight" rating in a research note on Tuesday, June 30th. Finally, UBS Group boosted their price objective on shares of UnitedHealth Group from $410.00 to $460.00 and gave the company a "buy" rating in a report on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $414.75.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company's stock, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.28% of the company's stock.

Institutional Investors Weigh In On UnitedHealth Group

Several hedge funds have recently added to or reduced their stakes in the business. Oberndorf William E purchased a new position in UnitedHealth Group during the third quarter worth approximately $12,276,000. Nordea Investment Management AB raised its stake in shares of UnitedHealth Group by 4.2% during the 4th quarter. Nordea Investment Management AB now owns 91,496 shares of the healthcare conglomerate's stock worth $30,287,000 after buying an additional 3,720 shares during the period. Capital Research Global Investors grew its stake in UnitedHealth Group by 126.9% in the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock valued at $4,503,419,000 after acquiring an additional 7,293,009 shares during the period. Vaughan David Investments LLC IL raised its position in UnitedHealth Group by 2.7% during the fourth quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate's stock worth $49,772,000 after acquiring an additional 3,934 shares during the period. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. lifted its holdings in UnitedHealth Group by 1,287.2% during the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock valued at $16,241,000 after purchasing an additional 55,695 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida's 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida's 27th Congressional District. She won in the general election on November 5, 2024. Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.